881 results on '"Allegra, Alessandro"'
Search Results
202. Phage–AgNPs complex as SERS probe for U937 cell identification
203. Efficacy of nilotinib in a young patient with high Sokal risk CML Ph+ in treatment failure after high dose imatinib
204. Plasma, Erythrocyte and Platelet Magnesium Levels in Type 1 Diabetic Patients with Microalbuminuria and Clinical Proteinuria
205. Efficacy and safety of 3 lenalidomide–based combinations in elderly newly diagnosed multiple myeloma patients: results from the phase 3 community based EMN01 trial
206. Reduction in IL–33 plasma levels might be involved in T–cell dysregulation in chronic lymphocytic leukemia
207. Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options
208. Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi
209. Primary plasma cell leukemia: a retrospective multicenter study of 73 patients
210. Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series
211. Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors
212. Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity
213. Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells
214. Correlazione del polimorfismo genico di MDR-1 con i nuovi marcatori prognostici in pazienti affetti da Leucemia Linfatica Cronica a cellule B
215. Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi
216. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders
217. MULTIDRUG RESISTANCE-1 GENE POLYMORPHISM ASSOCIATED WITH THE NEW MARKER OF DISEASE PROGRESSION AND POOR PROGNOSIS IN b-CELL CHRONIC LIMPHATIC LEUKEMIA
218. Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw
219. JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease
220. Sarcoglycans and integrins in gingival epithelium during biphosphonates treatment: immunohistochemical study
221. Interleukin-17 reduced serum levels in BRONJ patients after Bisphosphonate administration
222. Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1
223. Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw
224. Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1
225. Evaluation of circulating endothelial progenitor cells in patients with bisphosphonate-associated osteonecrosis of the jaw
226. Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases
227. Valutazione della concentrazione di precursori circolanti delle cellule endoteliali in corso di gravidanza normale ed in gravide affette da diabete gestazionale ed insufficienza gravidica
228. Serum levels of Interleukin-16 as an important prognostic factor in multiple Myeloma patient with cutaneous involvement
229. How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma.
230. Telomerase and telomere biology in hematological diseases: A new therapeutic target.
231. Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review).
232. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
233. Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells.
234. The metabolomic signature of hematologic malignancies.
235. The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
236. Phage display as a tool for rapid in vitro cell characterization by fluorescence imaging and Raman spectroscopy
237. Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura
238. Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab
239. New orally active proteasome inhibitors in multiple myeloma
240. Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia
241. Is apoptosis cause of pre-eclampsia?
242. VALUTAZIONE DELL'INQUINAMENTO ACUSTICO IN UNA AZIENDA OSPEDALIERA
243. VALUTAZIONE DEL PARTICOLATO ATMOSFERICO IN UNA AZIENDA OSPEDALIERA
244. Pro-apoptotic effect of fluvastatin on human smooth muscle cells
245. VALUTAZIONE DEI LIVELLI DI RADON INDOR IN UNA AZIENDA OSPEDALIERA
246. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects
247. Influenza dei farmaci sulla qualità di vita del soggetto uremico
248. [Recombinant erythropoietin and cardiovascular risk in uremia]
249. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse
250. Leptin: adipocyte hormone
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.